Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
48.3M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
513K
-
Shares change
-
+14.2K
-
Total reported value, excl. options
-
$4.39M
-
Value change
-
+$237K
-
Number of buys
-
12
-
Number of sells
-
-4
-
Price
-
$8.57
Significant Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q4 2023
18 filings reported holding INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value as of Q4 2023.
INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 513K shares
of 48.3M outstanding shares and own 1.06% of the company stock.
Largest 10 shareholders include SAPIENT CAPITAL LLC (200K shares), VANGUARD GROUP INC (83.1K shares), GEODE CAPITAL MANAGEMENT, LLC (45.4K shares), HOHIMER WEALTH MANAGEMENT, LLC (44.8K shares), Sigma Planning Corp (34.4K shares), Mesirow Financial Investment Management, Inc. (34.2K shares), HRT FINANCIAL LP (31.9K shares), STATE STREET CORP (14.5K shares), BlackRock Inc. (11K shares), and Qube Research & Technologies Ltd (6.16K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.